Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?
Kokkonen
Jorma O
JO
Lindstedt
Ken A
KA
Kovanen
Petri T
PT
D000804:Angiotensin II / Q000096:biosynthesis / Q000502:physiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D053818:Chymases; D004195:Disease Models, Animal; D004285:Dogs; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005110:Extracellular Space / Q000201:enzymology; D006333:Heart Failure / Q000201:enzymology*; D006801:Humans; D066298:In Vitro Techniques; D008407:Mast Cells / Q000201:enzymology; D051379:Mice; D009206:Myocardium / Q000201:enzymology; D007703:Peptidyl-Dipeptidase A / Q000187:drug effects / Q000378:metabolism; D012697:Serine Endopeptidases / Q000187:drug effects / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000378:metabolism
D000806:Angiotensin-Converting Enzyme Inhibitors; D004791:Enzyme Inhibitors; D016212:Transforming Growth Factor beta; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D012697:Serine Endopeptidases; D053818:Chymases